NS · Pharmaceuticals

RPG Life Sciences Ltd (RPGLIFE)

Pharmaceuticals & Biotechnology

RPG Life Sciences Ltd (RPGLIFE) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $37.80B, P/E ratio is 32.81, net margin is 19.4%, dividend yield is 0.88%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for RPGLIFE

Market cap

$37.80B

P/E ratio

32.81

Net margin

19.4%

Dividend yield

0.88%

RPG Life Sciences Ltd (RPGLIFE) — FAQ

What is RPG Life Sciences Ltd's market cap?

RPG Life Sciences Ltd (RPGLIFE) has a reported market cap of $37.80B (data as of 2026-07-10).

What is RPGLIFE's P/E ratio?

The price-to-earnings (P/E) ratio for RPG Life Sciences Ltd (RPGLIFE) is 32.81 (data as of 2026-07-10).

Does RPG Life Sciences Ltd pay a dividend?

RPG Life Sciences Ltd (RPGLIFE) shows a reported dividend yield of 0.88%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is RPG Life Sciences Ltd in?

RPG Life Sciences Ltd (RPGLIFE) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is RPGLIFE listed on?

RPGLIFE is listed on NS.

What is RPG Life Sciences Ltd's net margin?

RPG Life Sciences Ltd (RPGLIFE) reports a net margin of 19.4% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)